In this study, we showed the elevated lncRNA MIAT/HMGB1 axis is responsible for IL6-mediated activation of the JAK2/STAT3 pathway to endow NPC cells with cisplatin resistance (Figure 7I). Here, JAK2 is linked to nasopharyngeal carcinoma.